Directly observed preventive therapy: Turning the tide against tuberculosis

Archives of Pediatrics and Adolescent Medicine

Volumn 150, Issue 7, 1996, Pages 727-729

  Kohn, Michael R ^a,b   Arden, Martha R ^a   Vasilakis, Jeanne ^a   Shenker, I Ronald ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0030006372     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1996.02170320073012     Document Type: Article

References (16)

1. Bureau of Tuberculosis Control, New York City Department of Health. Tuberculosis in New York City 1993 - Information Summary. New York, NY: Dept of Health; 1993.
2. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin skin reaction in childhood and adolescence. Am J Epidemiol. 1974;99:131-137.
3. Barry MA, Shirley L, Grady MT, et al. Tuberculosis infection in urban adolescents: results of a school based testing program. Am J Public Health. 1990; 80:439-441.
4. Bye MR, Glaser JH, Hall CB, et al; Marshman FC, ed. Prevention and Control of Pediatric Tuberculosis in New York City: Recommendations of the Expert Advisory Panel. New York, NY: Dept of Health; 1995.
5. DeStefano FR. Pediatric TB moves to forefront; experts consider options. Infect Dis. 1994;7:15.
6. Thoren H. Multidrug resistant TB continues to plague California high school. Pediatr News. September 1994:19.
7. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general view. Adv Tuberc Res. 1969;17:29-106.
8. Snider DE. Decision analysis for isoniazid preventive therapy: take it or leave it? Am Rev Respir Dis. 1988;137:2-4.
9. Fox W. Compliance of patients and physicians: experience and lessons from tuberculosis - II. BMJ. 1983;287:101-105.
10. McKenna MT, McCray E, Onorato I. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986-1993. N Engl J Med. 1995; 332:1071-1076.
11. Hostetter MK, Iverson S, Thomas W, McKenzie D, Dole K, Johnson DE. Medical evaluation of internationally adopted children. N Engl J Med. 1991;325: 479-485.
12. Fox AS, Lepow ML. Tuberculin skin testing in Vietnamese refugees with a history of BCG vaccination. AJDC. 1983;137:1093-1094.
13. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the ratios of drug resistance and relapse in tuberculosis. N Engl J Med. 1994; 330:1179-1184.
14. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health care facilities, 1994. MMWR Morb Mortal Wkly Rep. 1994;43(RR-13):4.
15. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin skin test in childhood and adolescence. Am J Epidemiol. 1974;99:131-137.
16. New York City Department of Health. 1993 annual summary - tuberculosis. City Health Inform. November/December 1994:14.